C12Y 305/03
In linear amidines
Official title: in linear amidines (3.5.3)
C12Y305/03 (In linear amidines) appears on 103 US grants and 191 published applications in this corpus.
Search patents in C12Y- Granted patents
- 103
- Published applications
- 191
- Assignees
- 105
- Inventors
- 365
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 2 |
| 2004 | 3 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 0 | 1 |
| 2008 | 2 | 2 |
| 2009 | 0 | 6 |
| 2010 | 0 | 4 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 8 |
| 2015 | 6 | 5 |
| 2016 | 6 | 9 |
| 2017 | 7 | 8 |
| 2018 | 6 | 17 |
| 2019 | 7 | 10 |
| 2020 | 12 | 10 |
| 2021 | 7 | 18 |
| 2022 | 5 | 19 |
| 2023 | 1 | 9 |
| 2024 | 5 | 16 |
| 2025 | 18 | 14 |
| 2026 | 10 | 18 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 305/03001Arginase45
- C12Y 305/03006Arginine deiminase40
- C12Y 305/03015Protein-arginine deiminase9
- C12Y 305/03003Creatinase , i.e. creatine amidinohydrolase5
- C12Y 305/03011Agmatinase5
- C12Y 305/03012Agmatine deiminase2
- C12Y 305/03018Dimethylargininase2
- C12Y 305/03007Guanidinobutyrase1
All 23 subgroupsShow fewer
- C12Y 305/03023N-succinylarginine dihydrolase1
- C12Y 305/03002Guanidinoacetase0
- C12Y 305/03004Allantoicase0
- C12Y 305/03005Formimidoylaspartate deiminase0
- C12Y 305/03008Formimidoylglutamase0
- C12Y 305/03009Allantoate deiminase0
- C12Y 305/0301D-arginase0
- C12Y 305/03013Formimidoylglutamate deiminase0
- C12Y 305/03014Amidinoaspartase0
- C12Y 305/03016Methylguanidinase0
- C12Y 305/03017Guanidinopropionase0
- C12Y 305/03019Ureidoglycolate hydrolase0
- C12Y 305/0302Diguanidinobutanase0
- C12Y 305/03021Methylenediurea deaminase0
- C12Y 305/03022Proclavaminate amidinohydrolase0
Recent patents
- Arginase 1 binders for inhibiting Arginase 1 activity15 Sep 2026US 12,735,506 B2Merck Sharp & Dohme Corp.
- Analyte sensors and sensing methods for detecting creatinine28 Jul 2026US 12,693,255 B2Abbott Diabetes Care Inc.
- Method and composition for treating arginase 1 deficiency7 Jul 2026US 12,673,093 B2Immedica Pharma AB
- Fluorescent biosensor for rapid determination of l-arginine2 Jun 2026US 12,644,110 B2The Hong Kong Polytechnic University
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
- Method and composition for treating arginase 1 deficiency24 Sep 2026US 2026/0284160 A1Immedica Pharma AB
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Reprogramming method27 Aug 2026US 2026/0250639 A1The Babraham Institute
- Enzyme co-immobilization for biosynthesis20 Aug 2026US 2026/0242427 A1The Chinese University of Hong Kong
Most cited
By later US patents
- Modified arginine deiminase102US 6,183,738 B2Phoenix Pharamacologics, Inc. · 2001
- Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy44US 9,453,227 B2City of Hope · 2016
- Cleavable lipids30US 9,717,690 B2RaNA Therapeutics, Inc. · 2017
- Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same19US 6,645,739 B2Phoenix Pharmacologies, Inc. · 2003
- Mutated form of arginine deiminase18US 6,635,462 B1Phoenix Pharmacologies, Inc. · 2003